Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis J Selkoe

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Neurochemical Research|October 31, 2003
Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl CotmanDennis J Selkoe
Nature Medicine|September 9, 2011
Resolving controversies on the path to Alzheimer's therapeuticsDennis J Selkoe
Nature Aging|April 19, 2024
The advent of Alzheimer treatments will change the trajectory of human agingDennis J Selkoe
Nature Cell Biology|November 2, 2004
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseasesDennis J Selkoe
Behavioural Brain Research|March 25, 2008
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behaviorDennis J Selkoe
Cold Spring Harbor Perspectives in Biology|May 18, 2011
Alzheimer's diseaseDennis J Selkoe
Annals of Neurology|March 28, 2015
The therapeutics of Alzheimer's disease: where we stand and where we are headingDennis J Selkoe
Nutrition Reviews|February 5, 2008
Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's diseaseDennis J Selkoe
Science (New York, N.Y.)|October 26, 2002
Alzheimer's disease is a synaptic failureDennis J Selkoe
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Amyloid beta-peptide is produced by cultured cells during normal metabolism: a repriseDennis J Selkoe
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Neurochemical Research|October 31, 2003
Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl CotmanDennis J Selkoe
Nature Medicine|September 9, 2011
Resolving controversies on the path to Alzheimer's therapeuticsDennis J Selkoe
Nature Aging|April 19, 2024
The advent of Alzheimer treatments will change the trajectory of human agingDennis J Selkoe
Nature Cell Biology|November 2, 2004
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseasesDennis J Selkoe
Behavioural Brain Research|March 25, 2008
Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behaviorDennis J Selkoe
Cold Spring Harbor Perspectives in Biology|May 18, 2011
Alzheimer's diseaseDennis J Selkoe
Annals of Neurology|March 28, 2015
The therapeutics of Alzheimer's disease: where we stand and where we are headingDennis J Selkoe
Nutrition Reviews|February 5, 2008
Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's diseaseDennis J Selkoe
Science (New York, N.Y.)|October 26, 2002
Alzheimer's disease is a synaptic failureDennis J Selkoe
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Amyloid beta-peptide is produced by cultured cells during normal metabolism: a repriseDennis J Selkoe
Pageof 24